Protect Your Workforce with Precision Containment Analysis
At Indivirtus Healthcare Services, our Surrogate Powder Testing services provide scientifically validated assessments of pharmaceutical containment systems. Using advanced detection methods and expertly engineered surrogate materials, we help you protect your workforce and products while ensuring full compliance with global regulatory standards.
Surrogate Powder Testing assesses how well your containment systems protect workers from potent pharmaceutical compounds. By using safe, specially designed materials that mimic real drugs, we measure containment performance to ensure worker safety and product integrity without exposure risks.
Potent compounds, including APIs and biologics, can cause serious harm if containment systems fail. Our comprehensive testing identifies potential weaknesses, validates system effectiveness, and ensures compliance with strict regulatory requirements, protecting both your people and operations.
Indivirtus Healthcare Services combines cutting-edge analytical techniques with deep regulatory expertise to deliver customized testing solutions. As your trusted CRO partner, we provide actionable insights that help maintain safe, compliant, and efficient pharmaceutical manufacturing operations.
At Indivirtus Healthcare Services, we follow a rigorous, science-based approach to validate pharmaceutical containment systems. Our process starts with a risk-based test protocol specifically designed for your equipment and compounds. We employ fluorescent tracers like sodium fluorescein for immediate breach detection, combined with carefully engineered lactose/naproxen blends that accurately replicate your target API particle characteristics. For biologic applications, we use specialized surrogate APIs to ensure test relevance.
Our comprehensive testing approach includes real-time airborne particle monitoring combined with synchronized video recording for precise contamination tracking. We create detailed 3D contamination maps using UV-visible tracers and perform quantitative analysis through HPLC, achieving remarkable detection limits as low as ng/cm². For cytotoxic applications, our ultra-sensitive LC-MS/MS analysis ensures exceptional accuracy. Every test includes worst-case scenarios—like equipment failures or incorrect PPE use—to thoroughly challenge your systems and confirm reliability. Results are compared against Occupational Exposure Limits (OELs) and aligned with ISPE SMEPAC guidelines.
Custom Risk-Based Test Protocol: Tailored acceptance criteria designed for your specific systems and compounds.
Detailed Contamination Heat Maps: High-resolution visual analysis identifying potential exposure risks.
Synchronized Video and Particle Data: Precise diagnostic tools for accurate contamination tracking.
Quantitative Performance Metrics: Data-driven validation results demonstrating system effectiveness.
OEB Compliance Analysis: Comprehensive evaluation against Occupational Exposure Band standards.
Engineering Improvement Roadmap: Prioritized recommendations to achieve optimal ALARP conditions.
Regulatory Documentation Package: Complete documentation ready for regulatory submission and audits.
Our Surrogate Powder Testing services meet the highest global regulatory standards, ensuring your containment systems are audit-ready and fully compliant with international requirements. By following industry-leading frameworks, we provide scientifically sound documentation that withstands regulatory scrutiny and gives you complete operational confidence.
Our Surrogate Powder Testing services are vital for pharmaceutical manufacturers working with high-potency compounds, APIs, or biologics. Whether you're commissioning new systems, conducting routine validation, or investigating containment issues, our services ensure safety and compliance. Primary applications include validating glovebox isolators, testing transfer systems, ensuring safety in cytotoxic drug production, and preparing for regulatory inspections by agencies like the FDA or EMA.
Indivirtus Healthcare Services brings together certified toxicologists and regulatory specialists with state-of-the-art analytical capabilities to deliver superior Surrogate Powder Testing solutions. Our scientifically robust approach ensures reliable results, fast turnaround times, and complete confidentiality to protect your sensitive data. With customized testing protocols and practical recommendations, we help you optimize containment performance, achieve regulatory compliance, and maintain operational excellence in your pharmaceutical manufacturing.
We match surrogates to APIs based on: 1) Particle size distribution (laser diffraction analysis), 2) Morphology (SEM imaging), 3) Electrostatic properties, and 4) Flow characteristics - using engineered lactose blends or custom particles when needed to accurately simulate challenging APIs.
Yes, we use: 1) Fluorescent tracers detectable at <1ng/cm², 2) LC-MS/MS analysis for specific surrogate compounds, and 3) Statistical extrapolation models to verify containment at required levels for ultra-potent compounds.
The updated Annex 1 requires: 1) Integration with Contamination Control Strategy, 2) More frequent performance verification, and 3) Linkage to media fill simulations for aseptic processes. Our testing protocols include these elements with documented correlations.
Synchronization allows: 1) Precise identification of contaminant-generating activities, 2) Correlation of particle counts with specific operations, and 3) Visual evidence for training and procedure optimization - creating a powerful diagnostic tool.
Yes, we've developed scalable methods for: 1) Bin blenders and fluid bed dryers, 2) Continuous manufacturing lines, and 3) Large-scale isolators - using distributed sampling arrays and computational fluid dynamics modeling to extrapolate results.
Surrogate Powder Testing validates the integrity of containment systems used for handling potent pharmaceutical compounds. It uses safe, engineered materials to simulate real-world conditions, ensuring worker safety, product purity, and regulatory compliance.
We employ advanced techniques including fluorescent tracers, real-time particle monitoring, and HPLC analysis with detection limits to ng/cm². For cytotoxic applications, we use ultra-sensitive LC-MS/MS, ensuring precise and reliable results.
Our testing adheres to ISPE SMEPAC Guidelines (2021), EU GMP Annex 1 (2022), OSHA 29 CFR 1910.1000, NIOSH Hazardous Drug Handling Guidelines, EMA Health Based Exposure Limits, and ISO 14644-7 for cleanroom isolators.
You'll receive a risk-based test protocol, detailed contamination heat maps, synchronized video/particle data, quantitative performance metrics, OEB comparative analysis, an engineering control roadmap, and regulatory-ready documentation.
This service is ideal for commissioning new containment systems, routine validation, troubleshooting breaches, or preparing for regulatory audits. It's essential for handling potent APIs, biologics, or cytotoxic drugs.
We follow strict confidentiality protocols and industry best practices to protect your proprietary data, ensuring your intellectual property and operational details remain completely secure.